Global science and the high-tech industry are joining forces for a monumental breakthrough in biomedicine. In October 2026, it was revealed that a large-scale initiative is underway to create "virtual cells" capable of digitally simulating the behavior of living organisms. Approximately $1.8 billion in joint investments from the U.S. government, leading tech giants Meta, Google DeepMind, and other reputable partners has already been channeled into this unique project.

Large-Scale Funding and Initiative Participants

This initiative is a strategic expansion of the Virtual Biology Initiative launched by the nonprofit research institute Biohub. Technology giants Google DeepMind, Meta, and pharmaceutical developer Isomorphic Labs are collectively investing $300 million into the development. For its part, the U.S. Department of Energy (DOE) is allocating over $500 million over five years to provide high-performance computing, detailed modeling, and biological measurements.

Additionally, the U.S. National Institutes of Health (NIH) are coordinating massive databases and resources that have previously received over $500 million in government budget investments. Biohub itself allocated a matching $500 million at the project's launch, directing the lion's share of funds toward purchasing cutting-edge equipment, including cryo-electron tomographs and advanced microscopes.

Overcoming the Main Barrier of AI in Medicine

Historically, the primary obstacle to the effective application of artificial intelligence in modern medicine has been a severe lack of standardized data on how living cells react to environmental changes or new pharmaceutical drugs. The new project aims to radically change this landscape by establishing a unified, open database.

This database will allow advanced neural networks to accurately simulate how cellular structures respond to any external stimuli before scientists and developers move on to costly and lengthy trials in real-world laboratories. As Alex Rives, head of scientific direction at Biohub, notes, an accurate predictive model of biology can radically accelerate scientific discoveries and deepen our understanding of the nature of many diseases.

Scientific Infrastructure and Technological Support

To implement such an ambitious project, the United States' most powerful scientific infrastructure has been mobilized. The Department of Energy provides developers with direct access to exascale supercomputers, modern X-ray and neutron radiation sources, and fully automated laboratories.

In turn, NVIDIA is supplying the project with high-performance graphics processing units (GPUs) of the next generation, specialized software, and deep technical expertise. To integrate disparate data from various instruments and tissues, Biohub is implementing uniform standards, linking the developments of the world's leading centers—including the Allen Institute, the Broad Institute, and the Human Cell Atlas consortium—into a single network.

Contradictory Data

During the analysis of financial reports and publications from specialized outlets regarding the Virtual Biology Data Initiative, certain discrepancies emerged in assessing the total volume of attracted funds. Some sources, citing Channel NewsAsia materials and Unite.ai analytical reviews, put the total investment volume at exactly $1.8 billion, factoring in all government funding, Biohub contributions, and tech corporation inputs. At the same time, individual news feeds focus exclusively on the public-private partnership amounting to $1.3 billion, excluding Biohub's initial capital expenditures for laboratory equipment. Nevertheless, the expert community agrees that the scale of financing is unprecedented for the field of digital biology.